These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10052864)

  • 1. Complementary measures for promoting insulin sensitivity in skeletal muscle.
    McCarty MF
    Med Hypotheses; 1998 Dec; 51(6):451-64. PubMed ID: 10052864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of troglitazone on substrate storage and utilization in insulin-resistant rats.
    Sreenan S; Keck S; Fuller T; Cockburn B; Burant CF
    Am J Physiol; 1999 Jun; 276(6):E1119-29. PubMed ID: 10362626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
    Hevener AL; Reichart D; Janez A; Olefsky J
    Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
    Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
    Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
    Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
    Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
    Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
    Dea MK; Van Citters GW; Ader M; Mittelman SD; Sunehag AL; Bergman RN
    Diabetes; 2000 Dec; 49(12):2087-93. PubMed ID: 11118011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central role of the adipocyte in insulin resistance.
    Bergman RN; Mittelman SD
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):205-21. PubMed ID: 10212835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts.
    Kellerer M; Kroder G; Tippmer S; Berti L; Kiehn R; Mosthaf L; Häring H
    Diabetes; 1994 Mar; 43(3):447-53. PubMed ID: 7508875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKC-mediated modulation of L-type calcium channels may contribute to fat-induced insulin resistance.
    McCarty MF
    Med Hypotheses; 2006; 66(4):824-31. PubMed ID: 16307847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
    Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats.
    Ide T; Nakazawa T; Mochizuki T; Murakami K
    Metabolism; 2000 Apr; 49(4):521-5. PubMed ID: 10778879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis.
    Zhang B; Saku K; Arakawa K
    Metabolism; 1997 Mar; 46(3):273-81. PubMed ID: 9054469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
    Chen CC; Wang HJ; Shih HC; Sheen LY; Chang CT; Chen RH; Wang TY
    J Formos Med Assoc; 2001 Mar; 100(3):176-80. PubMed ID: 11393112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes.
    Meyer MM; Levin K; Grimmsmann T; Perwitz N; Eirich A; Beck-Nielsen H; Klein HH
    Diabetes; 2002 Sep; 51(9):2691-7. PubMed ID: 12196460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.
    Anil Kumar KL; Marita AR
    Br J Pharmacol; 2000 May; 130(2):351-8. PubMed ID: 10807673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance.
    He J; Xu C; Kuang J; Liu Q; Jiang H; Mo L; Geng B; Xu G
    Metabolism; 2015 Jul; 64(7):826-36. PubMed ID: 25825274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects.
    Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
    J Clin Endocrinol Metab; 1998 May; 83(5):1636-43. PubMed ID: 9589670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.